News from the FDA/CDC
News
FDA authorizes baricitinib combo for COVID-19
News
FDA approves first at-home COVID-19 test kit
The Lucira COVID-19 All-In-One Test-Kit is a single-use test that has a nasal swab to collect samples for people ages 14 and older.
News
Nearly 10% of hospitalized patients with COVID-19 later readmitted
News from the FDA/CDC
CDC panel takes on COVID vaccine rollout, risks, and side effects
ACIP will need to offer direction on which groups should get priority in vaccine allocation, inasmuch as early supplies will not be sufficient to...
News from the FDA/CDC
Teen vaping in the time of COVID-19
occurred...
News from the FDA/CDC
Systemic sclerosis patients share their perspectives and needs in treatment trials
FDA officials and clinical researchers heard about the impact that different symptoms have on patients’ daily lives in order to design better...
News from the FDA/CDC
FDA issues new NSAIDs warning for second half of pregnancy
The FDA action expands on earlier warnings about agents in this drug class, which the FDA previously cautioned about taking after week 30 of...
News
FDA posts COVID vaccine guidance amid White House pushback
In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization,...
News from the FDA/CDC
Golimumab approval extended to polyarticular-course JIA and juvenile PsA
The expanded approval to include pediatric indications came as part of a review of a clinical trial mandated by the Pediatric Research Equity Act...
News from the FDA/CDC
FDA adds polyarticular-course JIA to approved indications for tofacitinib
The approval is the fourth indication in the United States for tofacitinib after approvals for treatment of adults with rheumatoid arthritis,...
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...